Research project
101080528 NOSEVAC
Innovative Nasal Vaccines to prevent pathogen colonization and infection in the upperrespiratory tract (NOSEVAC)
date_range
Duration: from 01 May 2023 to 30 April 2028
(60 months)
With a Private character. It has been granted under a regime of Competitive.
In collaboration with other entities.
Call:
1008
HORIZON-HLTH-2022-DISEASE-06-two-stage
Program:
Pillar 2-Global Challenges and European Industrial Competitiveness
Researchers
NOEMI STEFANIA
CSABA
Leader